{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T22:40:44Z","timestamp":1781304044695,"version":"3.54.1"},"reference-count":40,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Lupus Foundation of America Gina M Finzi Student Fellowship for Mitra Moazzami"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Lupus"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Fatigue is one of the most common symptoms reported in patients living with SLE. We aim to: 1) determine if different trajectories of fatigue associate with specific latent classes of disease activity and 2) define the patient characteristics and associated factors in different latent classes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data from an inception cohort of adult patients from the Toronto Lupus Clinic from 1997-2018 were analyzed. Fatigue levels were measured using Fatigue Severity Scale (FSS) and disease activity by the Adjusted Mean Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) (AMS). Dual latent class trajectory analysis, for fatigue and AMS, was performed. Univariable and multivariable logistic regression analyses assessed the association of baseline variables with class membership.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 280 patients, 4 dual classes (C) of fatigue and disease activity were identified: C1- lowest disease activity and second highest fatigue trajectory (27%); C2- second highest disease activity and highest fatigue trajectory (30%); C3-moderate disease activity and lowest fatigue trajectory (33%); and C4- highest disease activity and moderate fatigue trajectory (10%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>4 distinct latent classes of dual fatigue and disease activity trajectories were identified. Fatigue and disease activity follow distinct trajectories and disease activity alone cannot fully explain fatigue trajectories. Trajectories with higher FSS scores were associated with more fibromyalgia and trajectories with higher disease activity were associated with higher cumulative glucocorticoid use. Higher baseline glucocorticoid use was more likely associated with more fatigue while older age at SLE diagnosis was associated with less fatigue.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/0961203320983892","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T19:28:54Z","timestamp":1610566134000},"page":"578-586","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":15,"title":["Dual trajectories of fatigue and disease activity in an inception cohort of adults with systemic lupus erythematosus over 10 years"],"prefix":"10.1177","volume":"30","author":[{"given":"Mitra","family":"Moazzami","sequence":"first","affiliation":[{"name":"George Washington University School of Medicine, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Strand","sequence":"additional","affiliation":[{"name":"Division of Immunology\/Rheumatology, Stanford University School of Medicine, Palo Alto, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiandong","family":"Su","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine; Toronto Western Hospital-Lupus Clinic; University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5177-2076","authenticated-orcid":false,"given":"Zahi","family":"Touma","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine; Toronto Western Hospital-Lupus Clinic; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","unstructured":"Kwan A Marzouk S Ghanean H et\u00a0al. (eds) Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus. Sem Arthritis Rheum 2019; 49: 260\u2013266.","DOI":"10.1016\/j.semarthrit.2019.03.004"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-017-0079-6"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-014-0116-1"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317749746"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.2217\/ijr.12.4"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22245"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313511554"},{"key":"e_1_3_2_9_2","first-page":"181","article-title":"The effects of fatigue and pain on daily life activities in systemic lupus erythematosus","volume":"27","author":"\u00d6zel F","year":"2015","unstructured":"\u00d6zel F, Argon G. The effects of fatigue and pain on daily life activities in systemic lupus erythematosus. A\u011fr\u0131 2015; 27: 181\u2013189.","journal-title":"A\u011fr\u0131"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24649"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0195579"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203316631632"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313502109"},{"key":"e_1_3_2_14_2","first-page":"117","article-title":"Fatigue and widespread pain in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome: symptoms of the inflammatory disease or associated fibromyalgia","volume":"30","author":"Iannuccelli C","year":"2012","unstructured":"Iannuccelli C, Spinelli F, Guzzo M, et\u00a0al. Fatigue and widespread pain in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome: symptoms of the inflammatory disease or associated fibromyalgia. Clin Exp Rheumatol 2012; 30: 117\u2013121.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_15_2","first-page":"790724","article-title":"Silent burdens in disease: fatigue and depression in SLE","volume":"2014","author":"Fonseca R","year":"2014","unstructured":"Fonseca R, Bernardes M, Terroso G, de Sousa M, Figueiredo-Braga M. Silent burdens in disease: fatigue and depression in SLE. Autoimmune Dis 2014; 2014: 790724.","journal-title":"Autoimmune Dis"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000031"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.100799"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa091"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.180831"},{"key":"e_1_3_2_21_2","first-page":"490","article-title":"Outcome measures to be used in clinical trials in systemic lupus erythematosus","volume":"26","author":"Strand V","year":"1999","unstructured":"Strand V, Gladman D, Isenberg D, Petri M, Smolen J, Tugwell P. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol 1999; 26: 490\u2013497.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_22_2","first-page":"635","article-title":"Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus","volume":"35","author":"Goligher EC","year":"2008","unstructured":"Goligher EC, Pouchot J, Brant R, et\u00a0al. Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. J Rheumatol 2008; 35: 635\u2013642.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1989.00520460115022"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.6.379"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket300"},{"key":"e_1_3_2_26_2","first-page":"373","article-title":"The systemic lupus International Collaborating Clinics\/American College of Rheumatology (SLICC\/ACR) damage index for systemic lupus erythematosus international comparison","volume":"27","author":"Gladman DD","year":"2000","unstructured":"Gladman DD, Goldsmith CH, Urowitz MB, et\u00a0al. The systemic lupus International Collaborating Clinics\/American College of Rheumatology (SLICC\/ACR) damage index for systemic lupus erythematosus international comparison. J Rheumatol 2000; 27: 373\u2013376.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_27_2","first-page":"1977","article-title":"Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus","volume":"30","author":"Iba\u00f1ez D","year":"2003","unstructured":"Iba\u00f1ez D, Urowitz MB, Gladman DD. Summarizing disease features over time: I. Adjusted mean SLEDAI derivation and application to an index of disease activity in lupus. The Journal of Rheumatology 2003; 30: 1977\u20131982.","journal-title":"The Journal of Rheumatology"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309346505"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa098"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400506"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.20982\/tqmp.05.1.p011"},{"key":"e_1_3_2_32_2","unstructured":"Abdi H. Bonferroni and \u0160id\u00e1k corrections for multiple comparisons. In: Neil Salkind (ed.) Encyclopedia of measurement and statistics. Vol. 3. Thousand Oaks CA: Sage 2007 pp.103\u2013107."},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","unstructured":"Nagin DS Nagin D. Group-based modeling of development. Harvard: Harvard University Press 2005.","DOI":"10.4159\/9780674041318"},{"key":"e_1_3_2_34_2","first-page":"1699","article-title":"Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support","volume":"32","author":"Jump RL","year":"2005","unstructured":"Jump RL, Robinson ME, Armstrong AE, Barnes EV, Kilbourn KM, Richards HB. Fatigue in systemic lupus erythematosus: contributions of disease activity, pain, depression, and perceived social support. J Rheumatol 2005; 32: 1699\u20131705.","journal-title":"J Rheumatol"},{"key":"e_1_3_2_35_2","first-page":"S40","article-title":"Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus","volume":"34","author":"Torrente-Segarra V","year":"2016","unstructured":"Torrente-Segarra V, Salman-Monte TC, R\u00faa-Figueroa \u00cd, et\u00a0al. Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus. Clin Exp Rheumatol 2016; 34: S40\u2013S47.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_36_2","first-page":"i114","article-title":"It hasn\u2019t gone away: the problem of glucocorticoid use in lupus remains","volume":"56","author":"Apostolopoulos D","year":"2016","unstructured":"Apostolopoulos D, Morand EF. It hasn\u2019t gone away: the problem of glucocorticoid use in lupus remains. Rheumatology 2016; 56: i114\u2013i122.","journal-title":"Rheumatology"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317716319"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12865-017-0200-5"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22101"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24052"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1177\/0961203318796293"}],"container-title":["Lupus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0961203320983892","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0961203320983892","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0961203320983892","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:23:26Z","timestamp":1777677806000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0961203320983892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1177\/0961203320983892"],"URL":"https:\/\/doi.org\/10.1177\/0961203320983892","relation":{},"ISSN":["0961-2033","1477-0962"],"issn-type":[{"value":"0961-2033","type":"print"},{"value":"1477-0962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]}}}